The Nasdaq slumped 3.23% this week, its worst drop since April 2025. Meta slid more than 11% after two court defeats, and Micron fell more than 15% as investors rotated out of the memory company ...

The US electric vehicle market has split into two diverging realities. New EV sales cratered 28% year-over-year in Q1 2026 to just 212,600 units, according to new data from Cox Automotive — but used ...

Software stocks dropped on Tuesday after a report on new AI tools from Amazon.com Inc. rekindled the disruption fears that have roiled the sector in the past few months. Amazon’s cloud-computing arm, ...

Dan is an assistant managing editor at Raw Story based in Colorado, producing and editing breaking political news. Dan previously worked as a news associate at The Associated Press in Philadelphia, ...

The 98th annual Academy Awards drew 17.86 million viewers on ABC and Hulu, which makes it the least-watched Oscars telecast since 2022. The number is down 9% from last year’s 19.7 million viewers, ...

Suddenly, “CBS Evening News” is back where executives at the news division behind the show hoped never to return. In contrast, ABC’s “World News Tonight,” long the leading program among the three ...

LONDON, March 16 (Reuters) - Daily oil exports from the Middle Eastern Gulf, home to top exporter Saudi Arabia and other major producers, have dropped by at least 60% in the week to March 15 compared ...

Traditional methods for creating dynamic drop-down lists in Excel, such as using INDIRECT or named ranges, often come with significant limitations. These approaches can break when tables are renamed, ...

In his first report as C.E.O., Gregory Abel, stuck to a straight commentary rather than Warren Buffett’s folksy tone. The lower earnings were largely driven by declines in the insurance business. By ...

Consumers likely won't see cheaper prices at the grocery store or shopping mall, economists say, despite the Supreme Court striking down many of President Trump's tariffs. There are a couple reasons ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price.

Eli Lilly (LLY) shares turned lower in the premarket on Tuesday after its rival Novo Nordisk (NVO) announced plans to cut the list prices of its GLP-1 medications, Wegovy, Ozempic, and Rybelsus, in ...